enquiry@dsij.in |+91 9240904920
SENSEX-307.24
76,957.27-0.4%

Tata Chemicals India strength offsets global soda ash margin pressure

Tata Chemicals Ltd.

Broker Recommendation:

HOLD

Broker: Motilal Oswal Financial Services Ltd. (MOFSL)

28 Jul 2026

Sector: Chemicals

Reco. Price

₹698

CMP

₹642.65

Target

₹700

Upside

0.29%

Investment View and Target Price

Motilal Oswal Financial Services, in its July 28, 2026 report on Tata Chemicals, reiterates its Neutral rating and sum-of-the-parts-based target price of Rs 700, compared with the CMP of Rs 698. The broker views Tata Chemicals' Indian operations as a relative strength, but believes weak international soda ash economics and persistent global oversupply limit near-term upside.

Motilal Oswal expects Tata Chemicals to deliver revenue and EBITDA CAGRs of 10 per cent and 27 per cent, respectively, over FY26-FY28.

Q1 FY27 Consolidated Performance

Tata Chemicals reported muted consolidated operating performance in Q1 FY27 despite outperforming Motilal Oswal's operating estimates. Consolidated revenue rose 14 per cent year on year to Rs 42,550 million, while EBITDA declined 15 per cent to Rs 5,550 million. EBITDA margin contracted 450 basis points year on year to 13.0 per cent. The company reported an adjusted net loss of Rs 170 million, compared with the broker's estimated adjusted profit of Rs 351 million.

Q1 FY27 metric Reported Motilal Oswal estimate Year-on-year change
Revenue Rs 42,550 million Rs 39,633 million Up 14 per cent
EBITDA Rs 5,550 million Rs 4,507 million Down 15 per cent
EBITDA margin 13.0 per cent Not provided Down 450 basis points
Adjusted net profit/(loss) Loss of Rs 170 million Profit of Rs 351 million Not provided

The weaker profitability reflected severe pressure in overseas operations. Tata Chemicals North America and Tata Chemicals Africa EBITDA fell 98 per cent and 94 per cent year on year, respectively, while Tata Chemicals Europe reported an EBITDA loss of Rs 50 million.

Indian Operations Remain the Key Positive

The Indian standalone business was the key positive in the quarter. Q1 FY27 revenue increased 10 per cent year on year to Rs 12,810 million and EBITDA rose 35 per cent to Rs 3,640 million. EBITDA margin expanded 530 basis points to 28.4 per cent.

Indian standalone metric Q1 FY27 Year-on-year change
Revenue Rs 12,810 million Up 10 per cent
EBITDA Rs 3,640 million Up 35 per cent
EBITDA margin 28.4 per cent Up 530 basis points
Salt volumes 402,000 tonnes Up 20 per cent
Soda ash volumes 195,000 tonnes Down 2 per cent
Bicarbonate volumes 43,000 tonnes Down 2 per cent

Higher realisations in soda ash, sodium bicarbonate and salt, together with operating efficiencies, supported margins. Management indicated an approximately Rs 2,000-per-tonne increase in soda ash prices, although contracts are quarterly, and guided Indian margins at around 18 per cent. Higher logistics costs from Indonesian coal imports and elevated limestone costs remain cost risks.

Global Soda Ash Conditions Remain Challenging

Management described global soda ash conditions as challenging. China has high inventory of 1.73 million tonnes, elevated exports and no significant production cuts, creating pricing pressure, especially in Southeast Asia.

North American Q1 FY27 soda ash volumes rose 13 per cent year on year to 614,000 tonnes and utilisation was 97 per cent. However, export-market realisations fell, with EBITDA per tonne declining to US$1 from US$41 a year earlier. Domestic US pricing was stable and exports to Latin America supported volumes.

Europe faced higher gas and fixed costs, including a one-off GBP2.4 million loss on the sale of UK ETS. Management targets breakeven from the next quarter and for FY27, assuming no further one-offs. In Africa, higher volumes were offset by lower pricing and higher heavy fuel oil costs in Kenya.

Portfolio Shift and Growth Initiatives

Management sees resilient Indian demand and stable domestic pricing as support for the Living Essentials portfolio, including salt, bicarbonates and prebiotics. Tata Chemicals is seeking to shift its portfolio from cyclical soda ash toward non-cyclical living essentials and silica.

  • An 82,500-tonnes-per-annum iodized vacuum salt dried plant at Mithapur is targeted to be operational by FY27-end and commissioned in Q1 FY28.
  • A 50,000-tonnes-per-annum precipitated silica plant is planned at Cuddalore.
  • A 210,000-tonnes-per-annum iodized vacuum salt dried plant is planned at Valinokkam.
  • A 40,000-tonnes-per-annum bicarbonate plant is planned in Singapore.

The company has also developed a sodium-ion battery-pack prototype for stationary energy storage systems and data centres. Pilot testing is expected to end within six to nine months, while full-scale production would require at least two years after product approvals.

Estimates and Valuation

Motilal Oswal broadly retained its consolidated FY27-FY28 EBITDA estimates, raising standalone assumptions but reducing international estimates.

Estimate Revision Revised estimate
FY27E EBITDA Reduced 4 per cent Rs 19,906 million
FY27E adjusted PAT Reduced 19 per cent Rs 3,291 million
FY28E EBITDA Reduced 2 per cent Rs 29,176 million
FY28E adjusted PAT Increased 3 per cent Rs 10,977 million

The valuation applies FY28 EV/EBITDA multiples of 7 times to India inorganic chemicals, 5 times to North America, and 5 times to Europe and Africa. It also incorporates discounted values for Rallis India and quoted investments. The broker retains a Neutral rating and a sum-of-the-parts-based target price of Rs 700.

Key Risks and Potential Positives

Key risks

  • Continued Chinese oversupply and weak international soda ash pricing.
  • Higher fuel, gas, freight and logistics costs.
  • A slower-than-expected cyclical recovery.

Potential positives

  • Sustained Indian demand and stable domestic prices.
  • Recovery in soda ash demand from solar glass and electric vehicles.
  • Successful execution of specialty, battery and expansion initiatives.
View / Download Original Research Report

Disclaimer: This is a summary of a research report published by the broker/research house identified above. The views, recommendations, target prices and estimates are those of the respective broker and do not represent DSIJ investment advice. The summary may be AI-assisted, hence please refer to the original report for complete details, disclosures and risks.